How the legal battle over abortion could thwart research, plus: the FDA ‘bully pulpit’ and Moderna’s future

Who should Bernie Sanders drag to DC next?

April 14, 2023 Check out STAT+

Sponsored By

Is pharma facing an existential threat? How do you get CEOs to speak out? And what's going on with Sarepta Therapeutics? We cover all that and more this week on "The Readout LOUD," STAT's biotech podcast. Jeremy Levin, CEO of Ovid Therapeutics, joins us to discuss a judge's decision to overturn the FDA approval of an abortion pill and why he believes it's the biggest threat to the biopharma industry in 50 years. We also cover the biggest news in the week of biopharma, including an update from Moderna, dispatches from a trip to FDA headquarters, and who Sen. Bernie Sanders has in his sights next. Listen Now Subscribe to the podcast to never miss an episode iTunes Spotify SoundCloud Stitcher TuneIn YouTube Visit the archive to see past episodes

---

---

Enjoying The Readout LOUD? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser